Yang Cheng

852 total citations
25 papers, 621 citations indexed

About

Yang Cheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yang Cheng has authored 25 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Yang Cheng's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Liver physiology and pathology (2 papers). Yang Cheng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Liver physiology and pathology (2 papers). Yang Cheng collaborates with scholars based in China, United Kingdom and Singapore. Yang Cheng's co-authors include Wanfu Xu, Lanlan Geng, Sitang Gong, Yun Zhu, Junhong Zhao, Peiyu Chen, Jiajia Xu, Min Yang, Kunyuan Wang and Jingjing Sun and has published in prestigious journals such as The FASEB Journal, Biosensors and Bioelectronics and Molecular Cancer.

In The Last Decade

Yang Cheng

22 papers receiving 617 citations

Peers

Countries citing papers authored by Yang Cheng

Since Specialization

Citations

This map shows the geographic impact of Yang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Cheng more than expected).

Fields of papers citing papers by Yang Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Cheng. The network helps show where Yang Cheng may publish in the future.

Co-authorship network of co-authors of Yang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Cheng. A scholar is included among the top collaborators of Yang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Cheng. Yang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PKN2 Inhibits VEGFA and bFGF‐Mediated Angiogenesis by Targeting HIF‐1α in Colon Cancer 2025 ·The Kaohsiung Journal of Medical Sciences ·Yun Zhu, S. Joseph Huang, Lei Yi, (unknown), (unknown), Biao Wang, Penghui Sun, Sitang Gong, Yang Cheng	1
2	Compensating control delays in the CFETR Multi-Purpose Overload Robot for divertor maintenance by using transformer-enhanced Temporal Convolutional Network 2025 ·Fusion Engineering and Design ·(unknown), (unknown), Hongbin Huang, Jie Liu, Youmin Hu, Hongtao Pan, Yong Cheng, Yang Cheng, Zhongxu Hu	0
3	Modeling of the shape of Taylor cone in EHD printing based on backpropagation neural network and genetic algorithm 2024 ·Journal of Electrostatics ·Yang Cheng, (unknown), Jianfeng Yu	2
4	WNT2B activates macrophages via NF‐κB signaling pathway in inflammatory bowel disease 2024 ·The FASEB Journal ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lanlan Geng, Yang Cheng, Sitang Gong	3
5	MicroRNAs in opisthorchiids and their definitive hosts: Current Status and Perspectives 2024 ·Molecular and Biochemical Parasitology ·Xiang Li, Jian Ding, Xiaoli Zhang, Xueli Zhang, (unknown), Rui Chen, Yang Cheng, (unknown), (unknown), Yu Zhang, Jianping Cao, (unknown)	0
6	WNT2B high‑expressed fibroblasts induce the fibrosis of IBD by promoting NK cells secreting IL-33 2024 ·Journal of Molecular Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Li Ma, (unknown), Xirong Chen, Lanlan Geng, Peiyu Chen, Huiwen Li, (unknown), (unknown), Yang Cheng, Sitang Gong	4
7	Synthesis and antitumor activity of some cholesterol-based selenocyanate compounds 2023 ·Steroids ·Yanmin Huang, Yang Cheng, (unknown), Liping Pang, Junyan Li, Jun‐An Xiao, Yuanfei Zhang, Jianguo Cui	5
8	Rabeprazole destroyed gastric epithelial barrier function through FOXF1/STAT3‐mediated ZO‐1 expression 2023 ·Clinical and Experimental Pharmacology and Physiology ·(unknown), (unknown), Yanhe Zhou, (unknown), (unknown), (unknown), Jing Huang, Yang Cheng, Lanlan Geng, Wanfu Xu, Sitang Gong	2
9	Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China 2021 ·Cancer Cell International ·Yun Zhu, (unknown), Kunyuan Wang, (unknown), (unknown), (unknown), Biao Wang, (unknown), Wenxuan Yu, Yang Cheng	22
10	Mast cells-derived MiR-223 destroys intestinal barrier function by inhibition of CLDN8 expression in intestinal epithelial cells 2020 ·Biological Research ·Musheng Li, Junhong Zhao, (unknown), (unknown), Guanhua Chen, Songyu Li, (unknown), Jing Xie, Yang Cheng, Ling Huang, (unknown), Yuxin Xu, (unknown), Kejian Zou, Lanlan Geng, Wanfu Xu, Sitang Gong	69
11	Omeprazole, an inhibitor of proton pump, suppresses De novo lipogenesis in gastric epithelial cells 2020 ·Biomedicine & Pharmacotherapy ·Peiyu Chen, (unknown), Hongli Wang, Junhong Zhao, Yang Cheng, Jing Xie, (unknown), (unknown), (unknown), Huan Chen, Jiayu Chen, (unknown), Yuxin Xu, (unknown), Lanlan Geng, Wanfu Xu, Sitang Gong	16
12	[Effect of Atractylodes macrocephala polysaccharide on proliferation and invasion of hepatocellular carcinoma cells in vitro]. 2019 ·PubMed ·Yun Zhu, Cheng Li, (unknown), Jingjing Sun, Yang Cheng	6
13	Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma 2019 ·EBioMedicine ·Yang Cheng, Kunyuan Wang, Lanlan Geng, Jingjing Sun, Wanfu Xu, (unknown), Sitang Gong, Yun Zhu	86
14	A far-red-emissive AIE active fluorescent probe with large stokes shift for detection of inflammatory bowel disease in vivo 2018 ·Journal of Materials Chemistry B ·Wanfu Xu, Liying He, (unknown), Chunhong Jia, Lanlan Geng, Min Yang, Zhaohui Xu, Peiyu Chen, Yang Cheng, Junhong Zhao, Hongli Wang, (unknown), (unknown), (unknown), Ruiyuan Liu	24
15	PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway 2018 ·Molecular Cancer ·Yang Cheng, Yun Zhu, Jiajia Xu, Min Yang, Peiyu Chen, Wanfu Xu, Junhong Zhao, Lanlan Geng, Sitang Gong	116
16	PKCα in colon cancer cells promotes M1 macrophage polarization via MKK3/6‐P38 MAPK pathway 2018 ·Molecular Carcinogenesis ·Yang Cheng, Yun Zhu, Wanfu Xu, Jiajia Xu, Min Yang, Peiyu Chen, Junhong Zhao, Lanlan Geng, Sitang Gong	31
17	Sorafenib and fluvastatin synergistically alleviate hepatic fibrosis via inhibiting the TGFβ1/Smad3 pathway 2017 ·Digestive and Liver Disease ·Yang Cheng, Hang Zheng, Biao Wang, Wanfu Xu, Jiajia Xu, Yun Zhu	18
18	Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma 2017 ·Oncotarget ·Yang Cheng, (unknown), Hang Zheng, Biao Wang, Yahui Liu, (unknown), (unknown), Wanfu Xu, Aimin Li, Yun Zhu	31
19	Polymer waveguide sensor for early diagnostic and wellness monitoring 2010 ·Biosensors and Bioelectronics ·(unknown), Yang Cheng, (unknown), Min Min Aung, (unknown), (unknown)	12
20	A Study on Vacuum Brazing Procedure of Plate Heat Exchanger 2004 ·Materials science forum ·(unknown), Yang Cheng, Lin Cheng	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact